Sponsor:
EMVision Medical Devices Ltd
Code:
NCT06999122
Conditions
Stroke
Hemorrhagic Stroke
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
Brain Scan
Brief summary:
Conditions
Stroke
Hemorrhagic Stroke
Study ID
NCT06999122
Start date
Mar 26, 2025
Status verified date
Jul, 2026
Completion date
Nov 28, 2026
Anticipated
Primary completion date
Nov 1, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Arms
Intracranial Haemorrhage Group A
Other Group B
Interventions
Brain Scan
Primary outcome measure
Central contacts
Locations
UCLA
Recruiting
Los Angeles, California, United States, 90095
Contacts
Principal Investigator:
May Nour, MD, PHD
Mayo Jacksonville
Recruiting
Jacksonville, Florida, United States, 32224
Contacts
Principal Investigator:
William Freeman, PhD
Mount Sinai West
Recruiting
New York, New York, United States, 10019
Contacts
Principal Investigator:
Hazem Shoirah, MD
Mount Sinai Health System
Recruiting
New York, New York, United States, 10029
Contacts
Principal Investigator:
Hazem Shoirah, MD
Memorial Hermann Memorial City Medical Center
Recruiting
Houston, Texas, United States, 77024
Contacts
Principal Investigator:
Aaron M Gusdon, PhD
UTHealth
Recruiting
Houston, Texas, United States, 77030
Contacts
Principal Investigator:
Aaron Gusdon, PhD
Sponsor
EMVision Medical Devices Ltd
Last update posted
Jul 27, 2026
Last verified
Jul, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-08. This information was provided to ClinicalTrials.gov by EMVision Medical Devices Ltd on 2026-07-27. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.